Clinical analysis of high-dose radiotherapy combined with chemotherapy for the treatment of rectal cancer
Shu Zhang,Xiaohao Wang,Weiwei Xiao,Qiaoxuan Wang,Zhifan Zeng,Peirong Ding,Gong Chen,Zhizhong Pan,Desen Wan,Yuanhong Gao
DOI: https://doi.org/10.13267/j.cnki.syzlzz.2018.02.002
2018-01-01
Abstract:Objective To analyze the efficacy and adverse effect of high-dose radiotherapy combined with chemotherapy in treating rectal cancer patients who failed to receive surgical treatment,and to explore the feasibility of high dose radiation in the special group of rectal cancer.Methods Fifty-two cases of rectal cancer patients who abandoned surgical treatment were treated with high-dose radiotherapy combined with chemotherapy.Radiotherapy includes three dimensional conformal radiation therapy (3D-CRT) or intensity modulated radiation therapy (IMRT).Patients who gave up surgery before any treatment received one course of high-dose radiotherapy [Gross tumor volume (GTV) 60-70 Gy/30-35 F with a median dose of 66 Gy,clinical target volume (CTV) 45-50 Gy/25 F].For patients who did not reach clinical complete response (cCR) after neoadjuvant or induced chemoradiotherapy and then abandoned surgical treatment,2 courses of radiotherapy were administered:GTV 45-50 Gy/25 F and CTV 45-46 Gy/25 F for the 1st course,and GTV 30 Gy/15 F for the 2nd course.The median total dose was 80 Gy and the median interval between the 2 courses was 71 d.The local recurrence or local progression rate,survival rate and therapeutic toxicity were analyzed for all-patient group,local advanced rectal cancer subgroup,and cCR subgroup.Results The median follow-up duration was 30 months.3-year local progression free survival (LPFS),progression free survival (PFS) and overall survival (OS) of all patients were 80.4％,65.7％ and 84.2％ respectively.For locally advanced patients,3-year LPFS,PFS and OS were 84.6％,68.1％ and 87.5％ respectively.For those who achieved cCR after high dose chemoradiotherapy,local recurrence rate was 12.9％,and 3-year LPFS,PFS and OS were 85.2％,73.9％ and 96.8％ respectively.No 4-5 level severe acute radiation adverse reactions was observed.Moreover,only 5.8％ of all patients developed chronic radiation proctitis that needs medical intervention.Conclusion High-dose radiation combined with chemotherapy can achieve satisfactory clinical outcome in rectal cancer patients who refuse surgery with tolerable acute and long-term therapeutic side effect.